Ads
related to: biotechnology examples
Search results
Should You Invest in the iShares Biotechnology ETF (IBB)?
Zacks via Yahoo Finance· 14 hours agoLooking for broad exposure to the Healthcare - Biotech segment of the equity market? You should...
AXIM Biotechnologies Receives Medical Device Manufacturing License
NewMediaWire via Yahoo Finance· 1 day agoState of California Department of Public Heath Food and Drug Branch Issues the Company a License for...
With 49% ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) has piqued the interest of institutional...
Simply Wall St. via Yahoo Finance· 4 days agoKey Insights Given the large stake in the stock by institutions, Puma Biotechnology's stock price...
The Biggest Biotechnology Company in Europe
Insider Monkey via Yahoo Finance· 4 days agoWe’ve recently covered a list of 20 Biggest Publicly-Traded Biotech Companies based on market caps that you can visit here. Biotechnology and Industry...
Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why
Zacks via Yahoo Finance· 6 days agoSales of Puma Biotechnology's (PBYI) sole marketed drug, Nerlynx, have been declining in recent...
Checking in on Sana Biotechnology Inc
Knox Daily· 1 day agoIn a filing, Sana Biotechnology Inc revealed its Director Yang Patrick Y unloaded Company’s shares for reported $0.24 million on Mar 08 ’24. In the deal valued at $9.45 per ...
U.S. Senators Alex Padilla and Todd Young Introduce Bills on Intersection of Biotech, Agriculture,...
Sierra Sun Times· 2 days agoSenators Alex Padilla (D-Calif.) and Todd Young (R-Ind.), both commissioners on the National...
Earnings call: CollPlant reports Q1 2024 results and corporate updates By Investing.com
Investing.com· 1 day agoCollPlant Biotechnologies (NASDAQ: CLGN) has released its financial outcomes for the first quarter...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 4 hours agoImmunocore is a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal ...
Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI...
Benzinga· 2 hours agoREDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ:JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting